MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-08-2026
OraSure Technologies Cash and Cash Equivalents 2011-2026 | OSUR
Annual Cash and Cash Equivalents OraSure Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 199 M | 268 M | 290 M | 84 M | 117 M | 161 M | 75.7 M | 88.4 M | 71 M | 108 M | 94.1 M | 92.9 M | 93.2 M | 87.9 M | 23.9 M | 73.8 M | 74.9 M | 39.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 290 M | 23.9 M | 113 M |
Quarterly Cash and Cash Equivalents OraSure Technologies
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 177 M | 216 M | 235 M | 248 M | 268 M | 279 M | 258 M | 247 M | 290 M | - | 186 M | 90.2 M | 84 M | 75.2 M | 66.2 M | 70.7 M | 117 M | 135 M | 158 M | 178 M | 161 M | 161 M | 161 M | 161 M | 75.7 M | 75.7 M | 75.7 M | 75.7 M | 88.4 M | 88.4 M | 88.4 M | 88.4 M | 71 M | 71 M | 71 M | 71 M | 108 M | 108 M | 108 M | 108 M | 94.1 M | 94.1 M | 94.1 M | 94.1 M | 92.9 M | 92.9 M | 92.9 M | 92.9 M | 93.2 M | 93.2 M | 93.2 M | 93.2 M | 87.9 M | 87.9 M | 87.9 M | 87.9 M | 23.9 M | 23.9 M | 23.9 M | 23.9 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 290 M | 23.9 M | 118 M |
Cash and Cash Equivalents of other stocks in the Medical instruments industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
3.56 M | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
111 M | $ 67.65 | -1.41 % | $ 13.5 B | USA |
 |
Glaukos Corporation
GKOS
|
90.8 M | $ 122.4 | -3.12 % | $ 7 B | USA |
 |
Alcon
ALC
|
1.53 B | $ 66.22 | -2.47 % | $ 40.4 B |  Schweiz |
 |
Intuitive Surgical
ISRG
|
3.37 B | $ 413.84 | -2.99 % | $ 148 B | USA |
 |
ICU Medical
ICUI
|
308 M | $ 141.46 | -0.38 % | $ 3.49 B | USA |
 |
iRhythm Technologies
IRTC
|
236 M | $ 113.35 | -0.42 % | $ 3.63 B | USA |
 |
Repro Med Systems
KRMD
|
8.87 M | $ 3.97 | -0.75 % | $ 183 M | USA |
 |
LeMaitre Vascular
LMAT
|
28.2 M | $ 93.09 | -3.63 % | $ 2.11 B | USA |
 |
Masimo Corporation
MASI
|
178 M | $ 179.95 | - | $ 9.59 B | USA |
 |
Microbot Medical
MBOT
|
3.91 M | $ 1.79 | -1.92 % | $ 82 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
1.17 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
1.11 M | $ 0.38 | -1.58 % | $ 31.2 M | USA |
 |
Merit Medical Systems
MMSI
|
446 M | $ 66.7 | -1.2 % | $ 3.95 B | USA |
 |
electroCore
ECOR
|
7.04 M | $ 10.04 | 5.46 % | $ 85.2 K | USA |
 |
Envista Holdings Corporation
NVST
|
1.21 B | $ 24.08 | -2.07 % | $ 4.05 B | USA |
 |
Haemonetics Corporation
HAE
|
245 M | $ 78.6 | -0.18 % | $ 3.71 B | USA |
 |
Isoray
ISR
|
30.6 M | - | 0.03 % | $ 108 M | USA |
 |
STERIS plc
STE
|
440 M | $ 206.71 | -2.9 % | $ 20.3 B | USA |
 |
STAAR Surgical Company
STAA
|
153 M | $ 29.65 | -0.74 % | $ 1.47 B | USA |
 |
InfuSystem Holdings
INFU
|
3.19 M | $ 8.86 | -1.88 % | $ 183 M | USA |
 |
Utah Medical Products
UTMD
|
85.8 M | $ 68.76 | 1.01 % | $ 223 M | USA |
 |
Teleflex Incorporated
TFX
|
379 M | $ 132.85 | -2.14 % | $ 5.93 B | USA |
 |
West Pharmaceutical Services
WST
|
791 M | $ 332.98 | -0.5 % | $ 24.1 B | USA |
 |
Pulse Biosciences
PLSE
|
80.7 M | $ 24.93 | -3.26 % | $ 1.68 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
326 M | $ 10.12 | -3.39 % | $ 2.02 B | USA |
 |
Retractable Technologies
RVP
|
2.59 M | $ 0.7 | 1.01 % | $ 21 M | USA |
 |
Pro-Dex
PDEX
|
419 K | $ 62.54 | -3.79 % | $ 206 M | USA |
 |
Predictive Oncology
POAI
|
10.8 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
33 M | $ 26.95 | -2.18 % | $ 1.29 B | USA |
 |
Stereotaxis
STXS
|
13.4 M | $ 1.83 | -1.35 % | $ 166 M | USA |
 |
Baxter International
BAX
|
1.97 B | $ 20.42 | 1.92 % | $ 10.5 B | USA |
 |
ResMed
RMD
|
274 M | $ 194.18 | -1.4 % | $ 28.4 B | USA |
 |
AtriCure
ATRC
|
167 M | $ 27.21 | -0.35 % | $ 1.3 B | USA |
 |
Harvard Bioscience
HBIO
|
8.61 M | $ 6.2 | 2.65 % | $ 275 M | USA |
 |
NeuroMetrix
NURO
|
1.43 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
55.9 M | $ 12.35 | 0.08 % | $ 505 M | USA |
 |
Becton, Dickinson and Company
BDX
|
641 M | $ 148.82 | -2.12 % | $ 42.8 B | USA |
 |
Nephros
NEPH
|
5.4 M | $ 3.24 | -0.31 % | $ 34.4 M | USA |
 |
Repligen Corporation
RGEN
|
566 M | $ 131.78 | 1.27 % | $ 7.41 M | USA |